Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months)

Completed · Phase 4 · Has a placebo group

Conditions studied: ADHD

In brief

A study to compare the effect of once-daily atomoxetine versus placebo in treating symptoms of ADHD in adults for up to 6 months.

Key facts

Study ID
NCT00190736
Run by
Eli Lilly and Company
People needed
440
Starts
2004-09-01
Expected to finish
2006-09-01
Last updated by the study team
2007-11-06

Who can join

Age: 18 and older, up to 54. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.